Angiographic and clinical results of everolimus-eluting stent utilization in saphenous vein graft lesions (ARES)

Int J Cardiol. 2015 Apr 1:184:433-435. doi: 10.1016/j.ijcard.2015.03.030. Epub 2015 Mar 4.
No abstract available

Keywords: Angiographic restenosis; Drug-eluting stents; Percutaneous coronary intervention; Saphenous vein graft lesion.

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angiography / methods
  • Angiography / statistics & numerical data
  • Angioplasty, Balloon* / adverse effects
  • Angioplasty, Balloon* / instrumentation
  • Angioplasty, Balloon* / methods
  • Aspirin / therapeutic use
  • Clopidogrel
  • Coronary Artery Bypass* / adverse effects
  • Coronary Artery Bypass* / methods
  • Coronary Disease / surgery*
  • Drug-Eluting Stents*
  • Everolimus / therapeutic use*
  • Female
  • Graft Occlusion, Vascular* / diagnosis
  • Graft Occlusion, Vascular* / physiopathology
  • Graft Occlusion, Vascular* / therapy
  • Humans
  • Male
  • Outcome Assessment, Health Care
  • Platelet Aggregation Inhibitors / therapeutic use
  • Reoperation / methods
  • Saphenous Vein* / diagnostic imaging
  • Saphenous Vein* / physiopathology
  • Saphenous Vein* / transplantation
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / therapeutic use

Substances

  • Platelet Aggregation Inhibitors
  • Everolimus
  • Clopidogrel
  • Ticlopidine
  • Aspirin